XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.26.1

EQUITY | 6 Months Ended
--- | ---
Jun. 27, 2026
EQUITY |
EQUITY | NOTE 4 - EQUITY Share repurchase program In April 2026, the Board of Directors authorized a program to repurchase up to $250 million of Mobileye’s outstanding Class A common stock (the “Repurchase Program”). Under the Repurchase Program, share repurchases may be made from time to time subject to general market conditions, opportunities and other factors. The Repurchase Program does not have a fixed expiration date and does not obligate the Company to acquire any specific dollar amount or number of shares. During the three and six months ended June 27, 2026, the Company repurchased 2,505,096 shares of outstanding Class A common stock for $23.5 million. Share-based compensation plans Mobileye Plan In June 2025, the stockholders of the Company approved the Amended and Restated Mobileye Global Inc. 2022 Equity Incentive Plan (the “2022 Plan”). Equity awards under the 2022 Plan are granted for Class A shares and vest upon the satisfaction of a service-based vesting condition, mostly over service periods of three years. Restricted Stock Units The RSU activity for the six months ended June 27, 2026 for RSUs granted to Company’s employees under the 2022 Plan was as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted average grant
​ | ​ | Number of RSUs | ​ | date fair value per share
​ | ​ ​ ​ | In thousands | ​ ​ ​ | U.S. dollars
Outstanding as of December 27, 2025 | ​ | 32,853 | ​ | $ | 20
Granted | ​ | 8,356 | ​ | ​ | 8
Vested | ​ | (1,450) | ​ | ​ | 19
Forfeited | ​ | (1,535) | ​ | ​ | 18
Outstanding as of June 27, 2026 | ​ | 38,224 | ​ | $ | 17
​ The RSU activity for the three months ended June 27, 2026 for RSUs granted to Company’s employees under the 2022 Plan was as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | ​ | ​ ​ ​ | Weighted average grant
​ | ​ | Number of RSUs | ​ | date fair value per share
​ | ​ | In thousands | ​ | U.S. dollars
Outstanding as of March 28, 2026 |  | 37,100 | ​ | $ | 18
Granted |  | 2,906 | ​ | ​ | 7
Vested |  | (1,054) | ​ | ​ | 17
Forfeited |  | (728) | ​ | ​ | 15
Outstanding as of June 27, 2026 |  | 38,224 | ​ | $ | 17
​ As of June 27, 2026, the unrecognized compensation cost related to all unvested RSUs granted under the 2022 Plan, was $344 million, which is expected to be recognized as an expense over a weighted-average period of 1.87 years. Restricted Shares In connection with the acquisition of Mentee Robotics, 23,651,844 Restricted Shares of Class A common stock were issued to the Mentee Founders. Such Restricted Shares were deposited with a deferred consideration trustee and will be released in equal portions twenty-four and forty-eight months after the closing date of February 3, 2026, subject to continued employment, or under certain circumstances affiliation, with the Company and its subsidiaries. For further detail, refer to Note 13 Business Combination. The Restricted Shares activity for the six months ended June 27, 2026 was as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Number of Restricted | ​ ​ ​ | Grant date fair value per
​ | ​ | Shares | ​ | share
​ | ​ | In thousands |  | U.S. dollars
Outstanding as of December 27, 2025 | ​ | — |  | $ | —
Granted | ​ | 23,652 |  | ​ | 9
Outstanding as of June 27, 2026 | ​ | 23,652 |  | $ | 9
​ The Restricted Shares activity for the three months ended June 27, 2026 was as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Number of Restricted | ​ ​ ​ | Grant date fair value per
​ | ​ | Shares | ​ | share
​ | ​ | In thousands | ​ | U.S. dollars
Outstanding as of March 28, 2026 |  | 23,652 | ​ | $ | 9
Outstanding as of June 27, 2026 |  | 23,652 | ​ | $ | 9
​ As of June 27, 2026, the unrecognized compensation cost related to all unvested Restricted Shares, was $186 million, which is expected to be recognized as an expense over a weighted-average period of 3.61 years. Share-based compensation expense summary Expenses recognized Share-based compensation expenses included in the condensed consolidated statements of operations and comprehensive income (loss) were as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | Six Months Ended
U.S. dollars in millions | ​ ​ ​ | June 27, 2026 | ​ ​ ​ | June 28, 2025 | ​ ​ ​ | June 27, 2026 | ​ ​ ​ | June 28, 2025
Cost of revenue | ​ | $ | 1 | ​ | $ | 1 | ​ | $ | 1 | ​ | $ | 1
Research and development, net (1) | ​ | ​ | 67 | ​ | ​ | 59 | ​ | ​ | 135 | ​ | ​ | 116
Sales and marketing | ​ | ​ | 1 | ​ | ​ | 2 | ​ | ​ | 3 | ​ | ​ | 3
General and administrative | ​ | ​ | 19 | ​ | ​ | 7 | ​ | ​ | 33 | ​ | ​ | 14
Total share-based compensation | ​ | $ | 88 | ​ | $ | 69 | ​ | $ | 172 | ​ | $ | 134
​ (1)Not including R&D Law incentive grant related to ordinary income from sold RSUs as further detailed in Note 2 under Research and Development Incentives, which depends on the actual sale of the shares of common stock issued upon the conversion of RSUs.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration